Mesoblast (MEOBF) Depreciation & Amortization - Total (2014 - 2018)
Mesoblast's (MEOBF) quarterly Depreciation & Amortization - Total came in at -$160000.0 in Q3 2018, up 40.07% year-over-year from -$114224.6 in Q3 2017, and up 40.07% quarter-over-quarter from -$267000.0 in Q3 2017.
Analysis
Mesoblast (MEOBF) Depreciation & Amortization - Total (2014 - 2018) Analysis & Trends
Mesoblast has disclosed Depreciation & Amortization - Total across 5 years of filings, most recently posting -$160000.0 for Q3 2018.
- In Q3 2018, Depreciation & Amortization - Total rose 40.07% year-over-year to -$160000.0; the TTM figure through Sep 2018 stood at -$1.2 million (up 15.83% YoY), while the FY2026 annual figure was -$481000.0, down 58.75% from the prior year.
- Depreciation & Amortization - Total came in at -$160000.0 for Q3 2018 at Mesoblast, up from -$267000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization - Total ranged from a high of -$160000.0 in Q3 2018 to a low of -$410000.0 in Q3 2016.
- Average Depreciation & Amortization - Total over 5 years is -$327600.0, with a median of -$394000.0 recorded in 2014.
- Year-over-year, Depreciation & Amortization - Total slipped 3.3% in 2015 and soared 40.07% in 2018.
- Over 5 years, Depreciation & Amortization - Total stood at -$394000.0 in 2014, then slipped by 3.3% to -$407000.0 in 2015, then fell by 0.74% to -$410000.0 in 2016, then jumped by 34.88% to -$267000.0 in 2017, then soared by 40.07% to -$160000.0 in 2018.
- Per Business Quant data, the three most recent Depreciation & Amortization - Total figures were -$160000.0 in Q3 2018, -$267000.0 in Q3 2017, and -$410000.0 in Q3 2016.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Tot) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.13 Bn | 9.29 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.23 Bn | 5.23 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.82 Bn | 3.52 Bn | 55.72 Mn | - |
| 4 | Legend Biotech | 3.68 Bn | 2.72 Bn | 251.50 Mn | - |
| 5 | uniQure | 3.08 Bn | 3.08 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 2.67 Bn | 2.67 Bn | - | - |
| 7 | Precigen | 2.43 Bn | 2.43 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.54 Bn | 251.87 Mn | - |
| 9 | Vericel | 2.00 Bn | 1.84 Bn | 56.40 Mn | - |
| 10 | Mesoblast | 246.02 Mn | 143.11 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2018 | -160,000.00 |
| Sep 30, 2017 | -267,000.00 |
| Sep 30, 2016 | -410,000.00 |
| Sep 30, 2015 | -407,000.00 |
| Sep 30, 2014 | -394,000.00 |